We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PhRMA is urging the FDA to withdraw or abbreviate its Part 11 regulation in favor of other more recently approved legislation dealing with the use of electronic records and signatures in day-to-day business, saying the rule is too prescriptive and the cost of compliance would be far too high.